🇺🇸 FDA
Pipeline program

Study 3: Chronic care management

19-4723

Phase 2 other completed

Quick answer

Study 3: Chronic care management for Smoking, Tobacco is a Phase 2 program (other) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Smoking, Tobacco
Phase
Phase 2
Modality
other
Status
completed

Clinical trials